Rituximab Maintenance In Patients With Chronic Lymphocytic Leukemia (Cll) After Upfront Treatment With Rituximab Plus Fludarabine, Cyclophosphamide, And Mitoxantrone (R-Fcm): Final Results Of A Multicenter Phase Ii Trial On Behalf Of The Spanish Cll Study Group (Gellc)
BLOOD(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要